INO: Inovio Net earnings per share for the last 12 months

Corporate company logo of Inovio Pharma (INO)

The net income per share trend, where the indicator value reaches -0.80, illustrates Inovio Pharmaceuticals (INO) transitioning toward the commercialization of its first DNA vaccine and the anticipation of the FDA verdict. Stable demand for the drugs is offset by risks of disruptions in Asian component supplies. Meanwhile, outsourcing production and testing to third-party contractors allows the company to focus on developing innovative medicines.

INO Inovio Pharma Net earnings per share for the last four quarters (07/04/2022 - 11/15/2026)

Financial and market metric breakdowns for Inovio Pharma (INO)

- current quotes and average value forecast:
Price Chart Inovio|INO - Fair Value Consensus
- market capitalization information:
Market Valuation Inovio Pharmaceuticals, Inc.|INO - Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Inovio|INO - Book Valuation of Business|Market Capitalization to Book Value Ratio inovio.com|INO - Company Total Asset Base
- debt level and financial liquidity data:
Debt to Equity Inovio Pharmaceuticals|INO - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Inovio Pharmaceuticals, Inc.|INO - Company Cumulative Debt|Debt to Book Value Inovio Pharmaceuticals Inc|INO - Company Long-Term Debt|Company Short-Term Debts Inovio|Quick Liquidity inovio.com
- earnings and multiples data:
INO - Company Net Income|Future Profit Inovio Pharmaceuticals|INO - Company Value to Net Income|Future Price to Earnings Inovio|INO - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple Inovio Pharma|INO - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Inovio|INO - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months inovio.com|INO - Earnings per share increase in current year|Net earnings per share growth forecast for next year Inovio Pharmaceuticals
- total revenue and sales volume data:
INO - Company Sales|Projected Sales Volume inovio.com|INO - P/S Multiple|Forward P/S Multiple Inovio Pharma|INO - Revenue Growth YoY (Last 12 Months)
Basic company analysis:Inovio - INO
Mass-produced product of Inovio Pharmaceuticals Inc

This metric is calculated by dividing the aggregate net income over the last four quarters by the total number of shares, determining the actual equity value of the business. For Inovio Pharmaceuticals (INO), which is completing its DNA therapy development cycle, the rolling annual earnings per share serves as an indicator of the transition from costly research to commercial implementation, where any positive momentum on the chart confirms the financial maturity of the pipeline.

Competitor analysis for Inovio Pharmaceuticals

Gilead - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Cidara Corp CDTX|Novavax Corp (NVAX) - Earnings per share for the last twelve months|CureVac N.V. - Earnings per share for the trailing year|Net earnings per share for the last 12 months VALN|Vir Biotechnology (VIR) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months SIGA Technologies Inc (SIGA)|EBS - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) AVIR (Atea Pharma)|Net earnings per share for the last four quarters Invivyd, Inc. (IVVD)|ENTA - Earnings per share for the last twelve months|Net earnings per share for the last four quarters hillevax.com HLVX|Kalaris Therapeutics (KLRS) - Earnings per share for the last twelve months|Dyadic International Inc (DYAI) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months NanoViricides Inc.|Talphera Corp - Earnings per one share for the last 12 months|Net earnings per share for the last 12 months COCP (Cocrystal Pharma Inc)|Net earnings per share for the last four quarters Traws Therapeutics|Earnings per share for the last twelve months Dogwood Therapeutics DWTX|Net earnings per share for the trailing year Qualigen Therapeutics, Inc.|ALVR - Earnings per share for the last twelve months|vbivaccines.com (VBIV) - Net earnings per share for the last 12 months|VIRI (virios.com) - Net earnings per share for the last 12 months|VXRT - Net earnings per share for the last four quarters